Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry-results

Cochlear Carina System CAMSEN post-market study

Also known as: Cochlear Carina System, Carina, CAMSEN, AI-5770, NCT04271761

Cochlear

Primary source

Company

Cochlear

Program Type

Device

Modality

Cochlear/Auditory Implant

Stage

Observational/NA

Status

Completed

Target Gene

—

Route / Mode

Totally implantable active middle-ear hearing implant

Confidence

86%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-09

Geography

Portugal

Population

adult, older-adult, hearing-impairment, middle-ear-implant, post-market

Trial IDs

Mechanism

Totally implanted active middle-ear implant system studied to characterize implanted microphone sensitivity and maximum stable gain in adult recipients.

Indications

Hearing Loss

Notes

Verified as a completed Cochlear-sponsored post-market observational study with posted results. Normalized from the generated intervention phrase to the product/study name and reclassified as an implantable device rather than generic hearing-aid/software.

Evidence & Sources

1 structured sources

clinicaltrials

Supports: canonicalName, aliases, company, programType, modality, stage, status, route...

IDs: NCT04271761, AI-5770, CAMSEN

Open

Key Events

2020-02-11

CAMSEN Carina System post-market study started

2021-07-16

ClinicalTrials.gov posted study results

Clinical Trials (1)